BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9346609)

  • 1. Long-term follow-up of the liver transplant recipient.
    Sorrell MF; Donovan JP
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):124-31. PubMed ID: 9346609
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow-up of the orthotopic liver transplantation patient.
    Zetterman RK; McCashland TM
    Semin Liver Dis; 1995 May; 15(2):173-80. PubMed ID: 7660170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation in children.
    Muiesan P; Vergani D; Mieli-Vergani G
    J Hepatol; 2007 Feb; 46(2):340-8. PubMed ID: 17161491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of parainfluenza virus type 3 infection with allograft rejection in a liver transplant recipient.
    Herzog KD; Dunn SP; Langham MR; Marmon LM
    Pediatr Infect Dis J; 1989 Aug; 8(8):534-6. PubMed ID: 2549495
    [No Abstract]   [Full Text] [Related]  

  • 5. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Follow-up of liver transplantation].
    Vasseur B; Samuel D
    Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B66-75. PubMed ID: 10897776
    [No Abstract]   [Full Text] [Related]  

  • 7. Postoperative care after liver transplantation.
    Shaw BW; Stratta RJ; Donovan JP; Langnas AN; Wood RP; Markin RJ
    Semin Liver Dis; 1989 Aug; 9(3):202-30. PubMed ID: 2554507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
    Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of living-related liver transplantation.
    Hayashi M; Cao S; Concepcion W; Monge H; Ojogho O; So S; Esquivel CO
    Pediatr Transplant; 1998 Feb; 2(1):16-25. PubMed ID: 10084755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart transplant. Long-term follow-up].
    Léger P; Desruennes M; Pavie A; Fraysse JB; Levasseur JP; Vaissier E; Cabrol C
    Ann Cardiol Angeiol (Paris); 1989 Sep; 38(7 Pt 2):499-503. PubMed ID: 2556068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection.
    Carbone J; Micheloud D; Salcedo M; Rincon D; Bañares R; Clemente G; Jensen J; Sarmiento E; Rodriguez-Molina J; Fernandez-Cruz E
    Transpl Infect Dis; 2008 Dec; 10(6):396-402. PubMed ID: 18657086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative care and problems in liver transplantation.
    Grenvik A; Gordon R
    Transplant Proc; 1987 Aug; 19(4 Suppl 3):26-33. PubMed ID: 3303531
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of the liver transplant patient].
    Renner EL
    Ther Umsch; 1998 Feb; 55(2):139-47. PubMed ID: 9545858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of patients after liver transplantation].
    De Gottardi A; Morard I; Dumortier J; Majno P; Mentha G; Giostra E
    Rev Med Suisse; 2006 Sep; 2(77):1952-4, 1957-9. PubMed ID: 17007450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function.
    Cywinski JB; Mascha E; Miller C; Eghtesad B; Nakagawa S; Vincent JP; Pesa N; Na J; Fung JJ; Parker BM
    Liver Transpl; 2008 Jan; 14(1):59-65. PubMed ID: 18161840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the Liver Transplant Recipient: Approach to Allograft Dysfunction.
    Fenkel JM; Halegoua-DeMarzio DL
    Med Clin North Am; 2016 May; 100(3):477-86. PubMed ID: 27095640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
    Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
    Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection.
    Ganschow R; Albani J; Grabhorn E; Richter A; Burdelski M
    Pediatr Transplant; 2006 Mar; 10(2):220-4. PubMed ID: 16573611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months.
    Orlando G; Manzia T; Baiocchi L; Sanchez-Fueyo A; Angelico M; Tisone G
    Transpl Immunol; 2008 Nov; 20(1-2):43-7. PubMed ID: 18773958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.